Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 9, 2011, Pages 1389-1394

  Sakai, Rika ^a   Kanamori, Heiwa ^b   Motohashi, Kenji ^b   Yamamoto, Wataru ^a   Matsuura, Shiro ^a   Fujita, Atsuko ^a   Ohshima, Rika ^a   Kuwabara, Hideyuki ^a   Tanaka, Masatsugu ^b   Fujita, Hiroyuki ^c   Maruta, Atsuo ^b   Ishigatsubo, Yoshiaki ^c   Fujisawa, Shin ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Allogeneic stem cell transplantation; Human herpesvirus 6 encephalitis; Quality of life; Sequela

Indexed keywords

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTEROGRADE AMNESIA; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; MALE; MENTAL DISEASE; MORTALITY; QUALITY OF LIFE; RISK FACTOR; SEIZURE; SURVIVAL TIME; TREATMENT DURATION; VIRUS ENCEPHALITIS;

ADULT; AMNESIA; CAUSE OF DEATH; CORD BLOOD STEM CELL TRANSPLANTATION; DATA COLLECTION; ENCEPHALITIS, VIRAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEIZURES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80051668519     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.01.014     Document Type: Article

References (21)

1. Okuno T., Takahashi K., Balachandra K., et al. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989, 27:651-653.
2. Bolle L.D., Naesens L., Clercq E.D. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005, 18:217-245.
3. Zerr D.M., Corey L., Kim H.W., et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:932-940.
4. Pagter P.F.A., Schuurman R., Visscher H., et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant 2008, 14:831-839.
5. Zerr D.M., Gupta D., Huang M.L., et al. Effect of antiviral on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:309-317.
6. Ogata M., Kikuchi H., Satou T., et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006, 193:68-79.
7. Yamane A., Mori T., Suzuki S., et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007, 13:100-106.
8. Aritaki K., Ohyashiki J.H., Suzuki A., et al. A rapid monitoring system of human herpesviruses reactivation by LightCycler in stem cell transplantation. Bone Marrow Transplantat 2001, 28:975-980.
9. Martin P.J., Schoch G., Fisher L., et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990, 76:1464-1472.
10. Noda Y., Kodama K., Yasuda T., Takahashi S. Calcineurin-inhibitor-induced pain syndrome after bone marrow transplantation. J Anesth 2008, 22:61-63.
11. Sashihara J., Tanaka-Taya K., Tanaka S., et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002, 100:2005-2011.
12. Kanda Y., Izutsu K., Hirai H., et al. Effect of graft-versus-host disease on the outcome of bone marrow transplantation from HLA-identical sibling donor using GVHD prophylaxis with cyclosporine A and methotrexate. Leukemia 2004, 18:1013-1019.
13. Fujimaki K., Mori T., Kida A., et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006, 84:432-437.
14. Zerr D.M. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006, 37:52-56.
15. Seeley W.W., Marty F.M., Holmes T.M., et al. Post-transplant acute limbic encephalitis. Clinical features and relationship to HHV6. Neurology 2007, 69:156-165.
16. Rapaport D., Engclhard D., Tagger G., Or R., Frenkel N. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis 2002, 4:10-16.
17. Tokimasa S., Hara J., Osugi Y., et al. Gancyclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002, 29:595-598.
18. Ogata M., Satou T., Kawano R., et al. Plasama HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008, 41:279-285.
19. Bethge W., Beck R., Jahn G., et al. Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation. Bone Marrow Transplant 1999, 24:1245-1248.
20. Manichanh C., Grenot P., Gautheret-Dejean A., et al. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometory analysis. Cytometry 2000, 40:135-140.
21. Deray G., Martinez F., Katlama C., et al. Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol 1989, 9:316-321.